AYTUHealthcareNano-Cap
AYTU BIOPHARMA, INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for AYTU BIOPHARMA, INC (AYTU), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are AYTU insiders buying or selling?
AYTU BIOPHARMA, INC insiders reported 12 open-market buys ($8.4M) and 4 sells ($40.6M) across 16 Form 4 filings — a net selling position of $32.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 10, 2025)
Total Form 4 filings
16
SEC EDGAR
Insider filers
7
Insider buys (12)
$8.4M
Insider sells (4)
$40.6M
Insider sentiment
Net sellingNet insider flow of $32.2M in net selling.
Recent AYTU insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2025 | Jarrett Disbrow | Chief Business Officer | Purchase | 16.7K | $1.50 | $25.0K |
| Jun 10, 2025 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 66.7K | $1.50 | $100.0K |
| Mar 3, 2025 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 15.0K | $1.30 | $19.5K |
| Jun 20, 2023 | Greg Pyszczymuka | Chief Commerical Officer | Purchase | 12.0K | $1.87 | $22.4K |
| Jun 15, 2023 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 14.0K | $1.86 | $26.1K |
| Dec 21, 2022 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 112.4K | $0.22 | $25.0K |
| Dec 21, 2022 | Greg Pyszczymuka | Chief Commercial Officer | Purchase | 100.0K | $0.24 | $24.5K |
| Nov 28, 2022 | Mark K Oki | Chief Financial Officer | Purchase | 90.0K | $0.23 | $20.7K |
| Nov 28, 2022 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 222.0K | $0.24 | $52.6K |
| Dec 16, 2020 | Steven Boyd | Director | Purchase | 1.3M | $6.00 | $8.0M |
| Apr 30, 2020 | Steven Boyd | Director | Sale | 5.1M | $1.82 | $9.3M |
| Apr 27, 2020 | Cerecor Inc. | 10% Owner | Sale | 92.8K | $1.55 | $144.1K |
| Mar 12, 2020 | Steven Boyd | Director | Sale | 22.0M | $1.42 | $31.2M |
| Dec 23, 2019 | Steven Boyd | Director, 10% Owner | Purchase | 78.8K | $0.86 | $67.7K |
| Dec 19, 2019 | Joshua R. Disbrow | Chief Executive Officer | Purchase | 55.0K | $0.89 | $48.8K |
| Dec 26, 2018 | David A Green | Chief Financial Officer | Sale | 3.3K | $0.81 | $2.7K |
Showing the 16 most recent of 16 Form 4 filings for AYTU BIOPHARMA, INC.
Most active AYTU insiders
- Joshua R. Disbrow6 filings
- Steven Boyd4 filings
- Greg Pyszczymuka2 filings
- Cerecor Inc.1 filing
- David A Green1 filing
Ask anything about AYTU insider activity
Use Trabud's AI agent to query AYTU BIOPHARMA, INC's Form 4 history in plain English — "Show me AYTU CEO purchases this year" or compare it against any other ticker.
Open the AI agentAYTU insider trading FAQ
Are AYTU BIOPHARMA, INC insiders buying or selling?
Across 16 SEC Form 4 filings, AYTU BIOPHARMA, INC (AYTU) insiders reported 12 open-market purchases totaling $8.4M and 4 sales totaling $40.6M. That is a net selling position of $32.2M.
How many insiders trade AYTU stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AYTU BIOPHARMA, INC. The most recent filing was accepted on Jun 10, 2025.
Where does Trabud get AYTU insider trading data?
All AYTU insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.